Insurance

Magazine articles on HMO's and other insurance companies.

Old Articles: <Older 921-930 Newer>

Managed Care July 2005 Tony Berberabe	Change in Thinking For Pharmacy Benefits in CDHP The difference between the pharmacy benefit in a consumer-directed health plan and a traditional health plan is greater generic drug utilization.
Managed Care July 2005 John Carroll	For More and More Workers, Small Pay Means Small Plans Some large health insurers are starting to offer limited-benefit plans for an unexpectedly vibrant niche - the working poor.
Managed Care July 2005 Martin Sipkoff	Is Pay for Performance Part of the Cure or the Problem? Paying for performance promises improved quality, reduced cost, and higher income for doctors. So why are some of them worried?
Managed Care July 2005 John A. Marcille	Talk About Consumer Plans Rapidly Becoming Reality After years of expectation and debate, consumer-directed health plans are all over the place.
Managed Care July 2005 Stanley Hochberg	Insurers Can No Longer Afford Not To Share Some Data Pay-for-performance programs imply improved patient care, but are frustrated by fragmented data collection and reporting systems.
Managed Care July 2005	Fear Called Primary Factor In How Coverage Is Chosen Fear and insecurity play a huge role in how people make decisions about health coverage, according to a study by Towers Perrin.
Managed Care July 2005	Two Major Studies Focus On Mental Health Two major studies on mental health say that while strides have been made in awareness of the problem and the willingness of patients to seek help, much more needs to be done.
Managed Care July 2005	Seeing is believing? Medicare reform seems to be taking root.
Managed Care July 2005 Martin Sipkoff	Support Grows for Establishing National Clinical Trial Registry Stakeholders are pushing for a national clinical trial registry, and efforts by UnitedHealth Group are in the forefront. Medical journals are setting hard and fast rules.
Managed Care July 2005	Cost being equal, consumers prefer older drugs Seven out of 10 consumers would prefer a drug that had been on the market for 10 years or more, compared to a newer drug, even if the copayments were equal. This could be a sign that consumers are more inclined to start using generic medications.
<Older 921-930 Newer> Return to current articles.